HeLa S3 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Reproductive system cancer cell lines

Organism

Human

Donor History

Adenocarcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: EMEM (MEM Eagle)

,

w: 2 mM L-Glutamine

,

w: 2.2 g/L NaHCO3

,

w: EBSS (Cytion article number 820100a). Supplements: Supplement the medium with 10% FBS and 1% NEAA. Dissociation reagent: Accutase. Seeding density: 1 x 10⁴ cells/cm². Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/HeLa-S3-Cells/300384

SKU: 300384 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The HeLa S3 cell line is a clonal derivative of the original HeLa cell line, which was established from the cervical cancer cells of an adult woman. HeLa S3 cells are notable for their robust growth in suspension cultures and are frequently used in scientific research due to their adaptability to various medium formulations. This variant retains the key characteristics of the HeLa lineage, such as a rapid doubling time and a karyotype that is highly aneuploid, displaying numerous chromosomal abnormalities which are a hallmark of HeLa cells.

HeLa S3 cells are widely utilized in virology, toxicology, and cancer research, particularly because they maintain the ability to be infected by poliovirus and other viruses, making them invaluable in pathogen-host interaction studies. They are also employed in the study of gene expression and regulation mechanisms under physiological and pathological conditions. The genetic and metabolic profiles of HeLa S3 have been extensively characterized, facilitating their use in high-throughput genetic screens and molecular biology applications.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.